Latest filing published 16 Jul 2026 for CYTOKINETICS INC, €5,417. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Nancy Wysenski, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cytokinetics Inc and Alkermes plc. In total, 32 filings cover trades dated from 12 May 2021 to 15 July 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 16 July 2026, reports a share grant of €5,417 in Cytokinetics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations